Characterization of osteoclasts derived from CD14+ monocytes isolated from peripheral blood
The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Abstract
Bone resorption is solely mediated by osteoclasts. Therefore, a pure osteoclast population is of high interest for the investigation of biological aspects of the osteoclasts, such as the direct effect of growth factors and hormones, as well as for testing and characterizing inhibitors of bone resorption. We have established a pure, stable, and reproducible system for purification of human osteoclasts from peripheral blood. We isolated CD14-positive (CD14+) monocytes using anti-CD14-coated beads. After isolation, the monocytes are differentiated into mature osteoclasts by stimulation with macrophage colony-stimulating factor (M-CSF) and receptor activator of nuclear factor kappaB ligand (RANKL). Osteoclast formation was only observed in the CD14+ population, not in the CD14- population, and only in the presence of both M-CSF and RANKL, confirming that the CD14+ system is a pure population of osteoclast precursors. No expression of osteoclast markers was observed in the absence of RANKL, whereas RANKL dose-dependently induced the expression of cathepsin K, tartrate-resistant acid phosphatase (TRACP), and matrix metallo proteinase (MMP)-9. Furthermore, morphological characterization of the cells demonstrated that actin rings were only formed in the presence of RANKL. Moreover, the osteoclasts were capable of forming acidic resorption lacunae, and inhibitors of lysosomal acidification attenuated this process. Finally, we measured the response to known bone resorption inhibitors, and found that the osteoclasts were sensitive to these and thereby provided a robust and valid method for interpretation of the effect of antiresorptive compounds. In conclusion, we have established a robust assay for developing osteoclasts that can be used to study several biological aspects of the osteoclasts and which in combination with the resorption marker CTX-I provides a useful tool for evaluating osteoclast function in vitro.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MOs stimulated with RANKL and M-CSF generate functional OCs [27], which degrade bone and express OC markers [28].”
From PU.1 target genes undergo Tet2-coupled demethylation and DNMT3b-mediated methylation in monocyte-to-osteoclast differentiation (2013) · cites this paper as [28]
Citations
Cites
Osteoclast differentiation and activation
Boyle, W. J., Simonet, W. S., & Lacey, D. L. (2003) · Nature · doi:10.1038/nature01658 · Cited by 6,670
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Bone Resorption by Osteoclasts
Teitelbaum, S. L. (2000) · Science · doi:10.1126/science.289.5484.1504 · Cited by 3,962
Manolagas, S. C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0395 · Cited by 2,568
Tjäderhane, L., Buzalaf, M. A. R., Carrilho, M., & Chaussain, C. (2015) · Caries Research · doi:10.1159/000363582 · Cited by 2,306
Bowman, E. J., Siebers, A., & Altendorf, K. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.21.7972 · Cited by 1,784
Genetic regulation of osteoclast development and function
Teitelbaum, S. L., & Ross, F. P. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1122 · Cited by 1,701
(2020) · Elsevier eBooks · doi:10.1016/c2015-1-01622-2 · Cited by 1,683
Principles of Bone Biology: By Bilezikian, Raisz and Rodan. Academic Press, London, U.K., 1996
Compston, J. E. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.2431019.x · Cited by 1,370
Yoshimori, T., Yamamoto, A., Moriyama, Y., Futai, M., & Tashiro, Y. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47429-2 · Cited by 1,328
Research works printed but not linked: 7
- GR Mundy, 1996, Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 16
- T Suda, 1996, Principles of Bone Biology, 87
- R Baron, 1986, Am J Pathol, 122, 363
- K Väänänen, 1996, Principles of Bone Biology, 103
- SC Manolagas, 2000, Endocr Rev, 21, 115
- M Horton, 1990, J Exp Pathol, 71, 741
- Y Okada, 1995, Lab Invest, 72, 311
Cited by
Osteoimmunology: Interactions of the Bone and Immune System
Lorenzo, J., Horowitz, M., & Choi, Y. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0038 · Cited by 563
“apy, and expanded stem cells in transplant recipients (36, 109).”
BackgroundHenriksen, K., Bollerslev, J., Everts, V., & Karsdal, M. A. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0006 · Cited by 230
Self-citationde la Rica, L., Rodríguez-Ubreva, J., García, M., Islam, A. B., Urquiza, J. M., Hernando, H., Christensen, J., Helin, K., Gómez-Vaquero, C., & Ballestar, E. (2013) · Genome Biology · doi:10.1186/gb-2013-14-9-r99 · Cited by 211
“MOs stimulated with RANKL and M-CSF generate functional OCs [27], which degrade bone and express OC markers [28].”
MiR-503 Regulates Osteoclastogenesis via Targeting RANK
Chen, C., Cheng, P., Xie, H., Zhou, H.-D., Wu, X.-P., Liao, E.-Y., & Luo, X.-H. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2032 · Cited by 214
“CD14þ peripheral blood mononuclear cells (PBMCs) serve as early progenitors of osteoclasts and are related to the pathophysiology of osteoporosis.((6,7)) Recent research revealed osteoclast formation in the presence of both macrophage colony‐stimulating factor (M‐CSF) and receptor activator of nuclear factor‐kB ligand…”
BackgroundMethodCheng, P., Chen, C., He, H.-B., Hu, R., Zhou, H.-D., Xie, H., Zhu, W., Dai, R.-C., Wu, X.-P., Liao, E.-Y., et al. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1845 · Cited by 195
“PBMCs were isolated from buffy coats (Duo-Add blood bags; Baxter, Deerfield, IL, USA) using Ficoll-Paque (Amersham Pharmacia Biotech, Roosendaal, Netherlands) as described.((11)) Before further purification, granulocyte contamination was reduced to <1% by a second Ficoll-Paque separation step.”
BackgroundMethodInfluential
Metadata
- Authors
- Sørensen, M. G., Henriksen, K., Schaller, S., Henriksen, D. B., Nielsen, F. C., Dziegiel, M. H., & Karsdal, M. A.
- Affiliations
- Nordic Bioscience (Denmark) (DK)
- Copenhagen University Hospital (DK)
- Corresponding author
- Karsdal, Morten Asser
- Venue
- Journal of Bone and Mineral Metabolism
- Published
- 2006-12-26
- Volume
- 25
- Issue
- 1
- Pages
- 36-45
- ISSN
- 0914-8779 (ISSN-L)
- 1435-5604
- OpenAlex
- W2094539147
- Cited by
- 143
- References
- 71
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 6 · 2023: 6 · 2022: 8 · 2021: 5 · 2020: 11 · 2019: 8 · 2018: 9 · 2017: 5 · 2016: 7 · 2015: 5 · 2014: 5 · 2013: 4 · 2012: 4
- FWCI
- 3.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Bone and Mineral Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Health Sciences › Medicine › Rheumatology › Osteomyelitis and Bone Disorders Research
- Keywords
- osteoclasts, osteoclastogenesis, CD14+ monocytes, bone resorption, RANKL, macrophage colony-stimulating factor, osteoclast precursors, cathepsin K, tartrate-resistant acid phosphatase, MMP-9, resorption lacunae, lysosomal acidification, antiresorptive agents, C-terminal telopeptide of type I collagen
- MeSH terms
- Animals, Blood, Cattle, Cell Differentiation, Female, Humans, Monocytes, Osteoclasts, Lipopolysaccharide Receptors, Microarray Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.